Search by Drug Name or NDC
NDC 54738-0981-60 Mucus Relief 400 mg/1 Details
Mucus Relief 400 mg/1
Mucus Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Richmond Pharmaceuticals, Inc.. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 54738-0981-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 54738-0981 |
---|---|
Product ID | 54738-981_5cc3bf1b-4684-6a53-e053-2a91aa0abfa6 |
Associated GPIs | 43200010000340 |
GCN Sequence Number | 051583 |
GCN Sequence Number Description | guaifenesin TABLET 400 MG ORAL |
HIC3 | B3J |
HIC3 Description | EXPECTORANTS |
GCN | 18906 |
HICL Sequence Number | 000271 |
HICL Sequence Number Description | GUAIFENESIN |
Brand/Generic | Generic |
Proprietary Name | Mucus Relief |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin 400 mg |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 400 |
Active Ingredient Units | mg/1 |
Substance Name | GUAIFENESIN |
Labeler Name | Richmond Pharmaceuticals, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 54738-0981-60 (54738098160)
NDC Package Code | 54738-981-60 |
---|---|
Billing NDC | 54738098160 |
Package | 60 TABLET in 1 BOTTLE (54738-981-60) |
Marketing Start Date | 2016-03-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 26924bee-32cc-4499-beb0-2650ff8eb1da Details
Uses
Warnings
Directions:
OTHER INFORMATION
Inactive ingredients
Questions or Comments
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
MUCUS RELIEF
guaifenesin 400 mg tablet |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Richmond Pharmaceuticals, Inc. (043569607) |
Registrant - Advance Pharmaceutical Inc. (078301063) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Advance Pharmaceutical Inc. | 078301063 | manufacture(54738-981) |
Revised: 10/2017
Document Id: 5cc3bf1b-4684-6a53-e053-2a91aa0abfa6
Set id: 26924bee-32cc-4499-beb0-2650ff8eb1da
Version: 2
Effective Time: 20171030